Skip to content
The Policy VaultThe Policy Vault

imatinib (generic)Medica

Acute lymphoblastic leukemia (Ph+ or ABL-class translocation)

Initial criteria

  • Patient has Philadelphia chromosome-positive acute lymphoblastic leukemia OR patient has ABL-class translocation

Approval duration

1 year